Adjuvant treatment of node-positive breast cancer with cyclophosphamide, doxorubicin, fluorouracil, and vincristine versus cyclophosphamide, methotrexate, and fluorouracil: final report after a 16-year median follow-up duration. (Q53368384)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Adjuvant treatment of node-positive breast cancer with cyclophosphamide, doxorubicin, fluorouracil, and vincristine versus cyclophosphamide, methotrexate, and fluorouracil: final report after a 16-year median follow-up duration. |
scientific article |
Statements
Adjuvant treatment of node-positive breast cancer with cyclophosphamide, doxorubicin, fluorouracil, and vincristine versus cyclophosphamide, methotrexate, and fluorouracil: final report after a 16-year median follow-up duration. (English)
1 reference
D Belpomme
1 reference
G Mathé
1 reference
J L Misset
1 reference
M di Palma
1 reference
M Delgado
1 reference
R Plagne
1 reference
P Chollet
1 reference
P Fumoleau
1 reference
B Le Mevel
1 reference
J Guerrin
1 reference
P Fargeot
1 reference
R Metz
1 reference
M Ithzaki
1 reference
C Hill
1 reference
1 April 1996
1 reference
14
1 reference
4
1 reference
1136-1145
1 reference
Identifiers
1 reference